Related Experiment Video
Updated: Aug 11, 2026
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 14, 2010
Respiratory allergy
1Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India. apcpgi@glide.net.in
Insights
Allergic rhinitis (AR) and asthma are rising global respiratory allergies in children. Early diagnosis and management, including specific immunotherapy (SIT), can prevent disease progression and improve quality of life.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
Background:
- Allergic rhinitis (AR) and asthma are prevalent, increasing global respiratory allergic diseases, particularly in developed nations.
- While childhood asthma is well-documented, less information exists on AR, a common childhood condition, significant asthma risk factor, and comorbidity affecting quality of life.
Purpose of the Study:
- To highlight risk factors for respiratory allergies like asthma and AR.
- To explore the linkages between these conditions and their management, focusing on allergological aspects in children.
- To emphasize the role of specific immunotherapy (SIT) in altering disease progression.
Main Methods:
- Review of existing literature on respiratory allergies, asthma, and allergic rhinitis.
- Analysis of risk factors, comorbidities, and management strategies.
- Discussion of the potential of specific immunotherapy (SIT) in pediatric respiratory allergy.
Main Results:
- Allergic rhinitis is a key risk factor for developing asthma and frequently co-exists with it.
- Effective management requires addressing allergological aspects and timely interventions.
- Specific immunotherapy (SIT) shows potential to modify disease natural history and prevent the 'allergic march'.
Conclusions:
- Integrated management of allergic rhinitis and asthma is crucial for children's health.
- Timely diagnosis, appropriate treatment, and referrals are essential for improving quality of life.
- Specific immunotherapy (SIT) offers a promising approach to prevent the progression of respiratory allergic diseases.
Abstract:
Allergic rhinitis (AR) and asthma are common respiratory allergic disorders which are increasing globally more in developed countries. Although much has been written about childhood asthma and guidelines published by various international and national fora, not much information is available on AR. This is most common in children, is a significant risk factor for developing asthma, is a common comorbidity with asthma and affects quality of life. This paper highlights the risk factors for developing respiratory allergy asthma and AR, linkages between them and the management issues, particularly in relation to the allergic or allergological aspects as they have important bearing on management of children suffering from respiratory allergy. Specific immunotherapy (SIT) is re-emerging as useful therapy which alone has the potential to modify the natural history of disease and prevent the 'allergic march'. Timely diagnosis, correct management including timely referrals can ensure good quality life for those suffering from respiratory allergies.
Related Concept Videos
02:06Allergic Reactions
01:31Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
01:30Allergic Reactions: Anaphylaxis
01:28Asthma I: Introduction